NEURIMMUNE
Table of contents:
The "NEURIMMUNE" trademark, serial number 85683759 , was filed on 22nd of July 2012 with a mark drawing code of 4000 and its transaction date is 85683759. Since 4th of February 2014, the document can be found in the M20 law office in the publication and issue section. The employee responsible is LEHKER, DAWN FELDMAN and the date it was published for opposition on 10/22/2013. The status of the trademark was checked last on 02/04/2014.
Prior registrations: 3727078 , 3727079
The corresponded responsible for this trademark is JANICE HOUSEY, located at SYMBUS LAW GROUP LLC, PO BOX 11085, MCLEAN, VA 22102.The state or country where the trademark was organized is by Neurimmune Holding Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Wagistrasse 13, Schlieren, zip 8952.
| GOODS AND/OR SERVICES | |
| International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. | |
|---|---|
| U.S. Class | 046 - Foods and Ingredients of Foods |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 001 |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 005 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 042 |
| International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 044 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| GS0011 | (Based on Intent to Use) Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicals, namely, synthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents |
| GS0051 | (Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases |
| GS0421 | (Based on 44(e)) (Based on Intent to Use) Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer software design, computer programming, or maintenance of computer software; computer hardware design and development; computer software design and development |
| GS0441 | (Based on 44(e)) (Based on Intent to Use) Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
| FOREGIN REGISTRATION | |
| Foreign Registration Date | 01/07/2008 |
|---|---|
| Foreign Expiration Date | 01/07/2018 |
| Country | CH |
| Foreign Registration Number | 571699 |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 02/04/2014 | CASE RETURNED TO EXAMINATION | I - Incoming Correspondence | OTHE - CASE RETURNED TO EXAMINATION | |
| 02/04/2014 | NOTICE OF ALLOWANCE CANCELLED | S | IUCN - NOTICE OF ALLOWANCE CANCELLED | |
| 12/17/2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 10/22/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 10/22/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 10/02/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
| 09/18/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 08/13/2012 | TEAS VOLUNTARY AMENDMENT RECEIVED | I - Incoming Correspondence | PARI - TEAS PRELIMINARY AMENDMENT RECEIVED | |
| 09/17/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 09/16/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 09/16/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 09/16/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 03/22/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 03/22/2013 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 03/22/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 03/19/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 03/18/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 03/18/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 02/28/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 02/28/2013 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 02/28/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 02/13/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 02/13/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/05/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 02/04/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 10/09/2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 10/09/2012 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 10/09/2012 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 10/09/2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 10/09/2012 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 10/09/2012 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 10/05/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 08/13/2012 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | I - Incoming Correspondence | TAEA | |
| 07/27/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 07/25/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "NEURIMMUNE" trademark, serial number 85683761 , was filed on 22nd of July 2012 with a mark drawing code of 3000 and its transaction date is 85683761. Since 4th of February 2014, the document can be found in the M20 law office in the publication and issue section. The employee responsible is LEHKER, DAWN FELDMAN and the date it was published for opposition on 10/22/2013. The date when we last checked the status of this trademark was 02/04/2014.
Prior registrations: 3727078 , 3727079
The corresponded responsible for this trademark is JANICE HOUSEY, located at SYMBUS LAW GROUP LLC, PO BOX 11085, MCLEAN, VA 22102.The state or country where the trademark was organized is by Neurimmune Holding Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Wagistrasse 13, Schlieren, zip 8952.
| GOODS AND/OR SERVICES | |
| International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. | |
|---|---|
| U.S. Class | 046 - Foods and Ingredients of Foods |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 001 |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 005 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 042 |
| International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 07/27/2012 |
| Primary Code | 044 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| DM0000 | The mark consists of the word "neurimmune" and a line design. |
| GS0011 | (Based on Intent to Use) Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicals, namely, synthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents |
| GS0051 | (Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases |
| GS0421 | (Based on 44(e)) (Based on Intent to Use) Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer software design, computer programming, or maintenance of computer software; computer hardware design and development; computer software design and development |
| GS0441 | (Based on 44(e)) (Based on Intent to Use) Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
| FOREGIN REGISTRATION | |
| Foreign Registration Date | 01/07/2008 |
|---|---|
| Foreign Expiration Date | 01/07/2018 |
| Country | CH |
| Foreign Registration Number | 571684 |
DESIGN SETUP
Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) . Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal . Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal .| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 02/28/2013 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 02/28/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 02/14/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 02/04/2014 | CASE RETURNED TO EXAMINATION | I - Incoming Correspondence | OTHE - CASE RETURNED TO EXAMINATION | |
| 02/04/2014 | NOTICE OF ALLOWANCE CANCELLED | S | IUCN - NOTICE OF ALLOWANCE CANCELLED | |
| 12/17/2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 10/22/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 10/22/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 10/02/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
| 09/18/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 09/17/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 09/16/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 09/16/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 09/16/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 03/22/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 03/22/2013 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 03/22/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 03/19/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 03/18/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 03/18/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 02/28/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 02/14/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/05/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 02/04/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 10/09/2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 10/09/2012 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 10/09/2012 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 10/05/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 08/13/2012 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | I - Incoming Correspondence | TAEA | |
| 08/13/2012 | TEAS VOLUNTARY AMENDMENT RECEIVED | I - Incoming Correspondence | PARI - TEAS PRELIMINARY AMENDMENT RECEIVED | |
| 07/28/2012 | NOTICE OF DESIGN SEARCH CODE MAILED | O - Outgoing Correspondence | MDSC | |
| 07/27/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 07/25/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.